{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T07:07:21Z","timestamp":1790665641483,"version":"4.1.0"},"reference-count":8,"publisher":"American Society of Hematology","issue":"24","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2020,12,10]]},"DOI":"10.1182\/blood.2020007766","type":"journal-article","created":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T17:00:51Z","timestamp":1607619651000},"page":"2725-2726","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":3,"title":["Can PET eradicate irradiation in PMBCL?"],"prefix":"10.1182","volume":"136","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0376-2559","authenticated-orcid":false,"given":"Eliza A.","family":"Hawkes","sequence":"first","affiliation":[{"name":"Olivia Newton-John Cancer Research Institute at Austin Health"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020121016355068800_B1","doi-asserted-by":"crossref","DOI":"10.1182\/blood.2019004296","article-title":"Outcome of primary mediastinal large B-cell lymphoma using R-CHOP: impact of a PET-adapted approach","author":"Hayden","year":"2020","journal-title":"Blood"},{"issue":"19","key":"2020121016355068800_B2","doi-asserted-by":"crossref","first-page":"5019","DOI":"10.1182\/blood-2011-01-293050","article-title":"The 2008 WHO classification of lymphoid neoplasms and beyond: evolving concepts and practical applications","volume":"117","author":"Campo","year":"2011","journal-title":"Blood"},{"issue":"10","key":"2020121016355068800_B3","doi-asserted-by":"crossref","first-page":"4626","DOI":"10.1002\/cam4.2347","article-title":"Real world experience of R-CHOP with or without consolidative radiotherapy vs DA-EPOCH-R in the first-line treatment of primary mediastinal B-cell lymphoma","volume":"8","author":"Chan","year":"2019","journal-title":"Cancer Med"},{"issue":"4","key":"2020121016355068800_B4","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1111\/bjh.14287","article-title":"Rituximab, cyclophosphamide, doxorubicin, vincristine and prednisolone (R-CHOP) in the management of primary mediastinal B-cell lymphoma: a subgroup analysis of the UK NCRI R-CHOP 14 versus 21 trial","volume":"175","author":"Gleeson","year":"2016","journal-title":"Br J Haematol"},{"issue":"5","key":"2020121016355068800_B5","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/ajh.24325","article-title":"Improved survival with combined modality therapy in the modern era for primary mediastinal B-cell lymphoma","volume":"91","author":"Jackson","year":"2016","journal-title":"Am J Hematol"},{"issue":"15","key":"2020121016355068800_B6","doi-asserted-by":"crossref","first-page":"1408","DOI":"10.1056\/NEJMoa1214561","article-title":"Dose-adjusted EPOCH-rituximab therapy in primary mediastinal B-cell lymphoma","volume":"368","author":"Dunleavy","year":"2013","journal-title":"N Engl J Med"},{"issue":"8","key":"2020121016355068800_B7","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.3324\/haematol.2018.192492","article-title":"End-of-treatment and serial PET imaging in primary mediastinal B-cell lymphoma following dose-adjusted EPOCH-R: a paradigm shift in clinical decision making","volume":"103","author":"Melani","year":"2018","journal-title":"Haematologica"},{"issue":"15","key":"2020121016355068800_B8","article-title":"Role of radiotherapy and dose-densification of R-CHOP in primary mediastinal B-cell lymphoma: a subgroup analysis of the UNFOLDER trial of the German Lymphoma Alliance [abstract]","volume":"38","author":"Held","year":"2020","journal-title":"J Clin Oncol"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/24\/2725\/1793687\/bloodbld2020007766c.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/136\/24\/2725\/1793687\/bloodbld2020007766c.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,12,10]],"date-time":"2020-12-10T17:00:55Z","timestamp":1607619655000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/136\/24\/2725\/474398\/Can-PET-eradicate-irradiation-in-PMBCL"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,12,10]]},"references-count":8,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,12,10]]}},"URL":"https:\/\/doi.org\/10.1182\/blood.2020007766","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,12,10]]}}}